Medical device and MedTech insights, news, tips and more

Mazor Receives Orders For 19 Surgical Robotic Systems

July 10, 2017

surgical robotic

surgical robotic

The surgical robotic company expects its second quarter revenue to reach $15.4 million.

Mazor Robotics Ltd. (Nasdaq: MZOR; TASE:MZOR) today announced that it had received 19 orders for its robot surgical systems in the second quarter of 2017. The company expects its second quarter revenue to reach $15.4 million, almost double its revenue in the second quarter last year.

16 of the orders are from US companies that bought the MazorX system, including seven upgrades of the company’s previous Renaissance system. The other three orders are for the slightly cheaper Renaissance system: one in the US and two elsewhere.

The orders are not part of those to which Medtronic is obligated under its cooperation agreement with Mazor; they are a real increase in the number of Mazor’s customers. The company’s orders backlog remains 14 systems, meaning that the company has managed to install many of the systems it sold in the preceding quarters.

Mazor reported the cancelation of one order, but CEO Ori Hadomi explained to “Globes” that the order involved was by a hospital for a specific department, and had been canceled in order to enable the hospital to order a system for a different department, so the cancelation had no business significance.

The growth in the number of systems ordered increases the likelihood that Medtronic will exercise its option in the second stage of its investment-commercial cooperation agreement with Mazor, including an order for hundreds of systems (amounting to tens, or even hundreds, of millions of dollars).

Read Full Article – Source: Globes English – Mazor receives orders for 19 robotic surgical systems

Author – Gali Weinreb, Globes [online], Israel Business News –

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.